Recovery & Repair
BPC-157
- Size
- 10mg
Specifications
BPC-157 Technical Profile
OVERVIEW
What Is BPC-157 Peptide?
BPC-157 is a synthetic peptide consisting of 15 amino acids. It is derived from a partial sequence of body protection compound (BPC), a protein naturally found in human gastric juice. First isolated and characterized in the early 1990s, BPC-157 peptide has become one of the most extensively studied peptides in preclinical research, with hundreds of published studies exploring its properties in laboratory and animal models.
As a research peptide, BPC-157 belongs to the class of gastric pentadecapeptides. Unlike many peptides that require specific environmental conditions to maintain stability, BPC-157 research has demonstrated notable stability in various pH environments. This characteristic, combined with its well-documented research profile, has made BPC-157 a foundational compound in peptide research laboratories worldwide.
- 01
Gastric Pentadecapeptide
Synthetic 15-amino-acid peptide derived from human gastric juice protein
- 02
≥99% HPLC Purity
Every batch verified via high-performance liquid chromatography
- 03
USA Tested & Verified
Third-party analytical testing performed in USA laboratories
RESEARCH
BPC-157 Mechanism of Action in Research
The BPC-157 mechanism of action has been a central focus of preclinical research for over two decades. Studies suggest that BPC-157 interacts with multiple biological pathways simultaneously, which distinguishes it from many single-target peptides. BPC-157 research continues to expand our understanding of how this peptide influences cellular and molecular processes in laboratory settings.
Nitric Oxide (NO) System Modulation
Research indicates that BPC-157 may interact with the nitric oxide system, a critical signaling pathway involved in vascular function. In laboratory studies, BPC-157 has been observed to modulate NO synthase activity, potentially influencing blood vessel formation and endothelial cell behavior. Published research suggests this interaction may be bidirectional, with BPC-157 appearing to promote or counteract NO system effects depending on the experimental context (Sikiric et al., 2014).
Growth Factor Pathway Interactions
Preclinical studies have explored how BPC-157 may influence growth factor expression. Research suggests BPC-157 may upregulate the expression of growth hormone receptors and interact with the FAK-paxillin pathway, which plays a role in cell adhesion and migration. Studies in animal models have indicated that BPC-157 research compounds may promote angiogenesis, the formation of new blood vessels, through VEGF-mediated pathways (Chang et al., 2011).
GABAergic and Dopaminergic System Interactions
Additional BPC-157 research has examined its potential interactions with central neurotransmitter systems. Studies indicate that BPC-157 may influence the dopaminergic and GABAergic systems, with researchers observing modulated behavior patterns in animal models. These findings have expanded the scope of BPC-157 research beyond its originally studied pathways.
COMPARISON
BPC-157 vs TB-500: Research Peptide Comparison
BPC-157
Both BPC-157 and TB-500 (Thymosin Beta-4 fragment) are among the most frequently studied peptides in preclinical research. While they share some overlapping areas of investigation, they differ significantly in structure, origin, and proposed mechanisms. Understanding these differences helps researchers select the appropriate compound for their specific laboratory protocols.
TB-500
Both peptides continue to be subjects of active investigation. Some researchers have explored their combined use in laboratory settings, though the majority of published literature examines each compound independently. VivePeptides offers both BPC-157 for sale and TB-500 at research grade purity from our USA-based facility.
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Origin | Derived from human gastric juice protein | Fragment of Thymosin Beta-4 |
| Amino Acids | 15 | 43 |
| CAS Number | 137525-51-0 | 77591-33-4 |
| Molecular Weight | 1419.53 Da | 4963.50 Da |
| Primary Research Focus | Gastric and tissue research | Cell migration and tissue research |
| Stability | Stable across various pH ranges | Requires careful storage |
| Proposed Mechanism | NO system, growth factor modulation | Actin sequestration, cell motility |
| Research Volume | 100+ published studies | 50+ published studies |
RESEARCH STUDIES
BPC-157 Research Applications & Published Studies
BPC-157 research spans more than two decades of published preclinical literature. The following areas represent the most actively investigated applications of BPC-157 peptide in laboratory and animal model studies. All references are to research contexts only.
Gastrointestinal Research
BPC-157 was originally isolated from gastric juice, and gastrointestinal research remains a primary area of investigation. Sikiric et al. (2003) published comprehensive reviews documenting BPC-157's effects in various GI models, observing that the peptide demonstrated notable activity in multiple experimental paradigms. Studies have examined BPC-157 in models of gastric lesions, intestinal anastomosis, and inflammatory bowel conditions in animal subjects (Sikiric et al., Journal of Physiology-Paris, 2003).
Musculoskeletal and Connective Tissue Studies
Published research has examined BPC-157 in animal models related to tendons, ligaments, and muscle tissue. Staresinic et al. (2003) reported observations of BPC-157's effects on Achilles tendon models in rats, while Pevec et al. (2010) published findings on BPC-157 in quadriceps muscle injury models. These studies contribute to the growing body of BPC-157 research focused on connective tissue biology.
Neuroprotective Research Models
More recent BPC-157 research has expanded into neuroscience applications. Klicek et al. (2013) and Tudor et al. (2010) published studies examining BPC-157 in various neural injury models in animal subjects. Research suggests the peptide may interact with neurotransmitter systems including the dopaminergic, serotonergic, and GABAergic pathways, though these findings remain in the preclinical stage.
QUALITY ASSURANCE
Quality & Testing Standards
VivePeptides maintains rigorous quality control for every batch of BPC-157 peptide. Our commitment to research-grade purity ensures that laboratories receive consistent, reliable compounds for their investigations.
HPLC & Mass Spectrometry
Every batch of BPC-157 undergoes high-performance liquid chromatography (HPLC) and mass spectrometry analysis to confirm identity, purity, and molecular weight.
Third-Party Verified
All VivePeptides BPC-157 is independently verified through third-party analytical laboratories based in the USA. Testing documentation is available for every lot.
≥99% Purity Standard
Our BPC-157 consistently meets or exceeds ≥99% purity as determined by HPLC analysis, ensuring research-grade quality for laboratory applications.
FAQ
Frequently Asked Questions About BPC-157
What is BPC-157 used for in research?
What purity is VivePeptides BPC-157?
How should BPC-157 be stored?
What is the difference between BPC-157 and BPC-157 acetate?
Is VivePeptides BPC-157 third-party tested?
Add To Research Cart
BPC-157
99%+ purity · USA lab tested · secure shipping
